On November 6, Ailang China and Sinopharm Group Shanghai Medical Devices Co., Ltd. (hereinafter referred to as “Sinopharm Shanghai Company”) signed a memorandum of strategic cooperation at the 6th Expo to establish a strategic cooperative relationship in the field of products and services, and cooperate in various areas such as hospital logistics supply, process management and logistics distribution, thus improving the overall quality of life of patients.
Shi Hua, global vice president of Ailang Medical and general manager of China, said that Alang Medical has long focused on interventional medicine, and its products mainly cover three areas: tumor intervention, vascular intervention, and nursing intervention. Today, the two sides signed a strategic cooperation agreement here, which will lay the foundation for deeper cooperation in the future, maximize efficiency through cooperation and innovation, and jointly empower clinicians and patients.
Wang Yiran, general manager of Sinopharm Group Shanghai Medical Devices Co., Ltd., said that as an important partner of Ailang China, Sinopharm Shanghai Medical Devices Co., Ltd. will help Elang get better promotion of its interventional products from multiple dimensions such as procurement, warehousing, warehouse matching, logistics, and distribution channels.
